Bioqual, Inc. (BIOQ)
USD 55.0
(-4.35%)
USD 55.0
(-4.35%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 3.03 Million USD | -10.29% |
| 2022 | 3.38 Million USD | -77.03% |
| 2021 | 14.76 Million USD | 13.11% |
| 2020 | 13.07 Million USD | 35.56% |
| 2019 | 9.77 Million USD | 115.4% |
| 2018 | 4.61 Million USD | -26.48% |
| 2017 | 6.07 Million USD | -15.55% |
| 2016 | 7.18 Million USD | 32.58% |
| 2015 | 5.45 Million USD | 32.19% |
| 2014 | 4.09 Million USD | 61.86% |
| 2013 | 2.53 Million USD | 372.42% |
| 2012 | 535.58 Thousand USD | 0.0% |
| 2010 | 1.48 Million USD | 0.24% |
| 2009 | 1.48 Million USD | 0.0% |
| 2006 | 2.24 Million USD | 26.85% |
| 2005 | 1.9 Million USD | -11.81% |
| 2004 | 2 Million USD | 15.04% |
| 2003 | 1.74 Million USD | 34.2% |
| 2002 | 1.3 Million USD | 0.0% |
| 2000 | 968.14 Thousand USD | 65.19% |
| 1999 | 586.09 Thousand USD | -31.07% |
| 1998 | 850.23 Thousand USD | 130.24% |
| 1997 | 369.28 Thousand USD | 9.96% |
| 1996 | 335.83 Thousand USD | -21.74% |
| 1995 | 429.14 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 644.67 Thousand USD | 154.78% |
| 2023 Q4 | -1.17 Million USD | -233.49% |
| 2023 Q3 | 881.62 Thousand USD | -26.75% |
| 2023 Q1 | 2.7 Million USD | 473.91% |
| 2023 Q2 | 1.2 Million USD | -55.47% |
| 2022 Q3 | 3.25 Million USD | -0.85% |
| 2022 Q2 | 3.27 Million USD | 67.81% |
| 2022 Q1 | 1.95 Million USD | -36.42% |
| 2022 FY | - USD | -52.87% |
| 2022 Q4 | 470.92 Thousand USD | -85.52% |
| 2021 Q4 | 3.07 Million USD | 23.32% |
| 2021 FY | - USD | 13.11% |
| 2021 Q3 | 2.49 Million USD | -58.65% |
| 2021 Q1 | 3.12 Million USD | -19.7% |
| 2021 Q2 | 6.02 Million USD | 92.93% |
| 2020 Q1 | 2.8 Million USD | 73.69% |
| 2020 Q3 | 1.71 Million USD | -27.79% |
| 2020 Q4 | 3.89 Million USD | 126.83% |
| 2020 FY | - USD | 35.56% |
| 2020 Q2 | 2.37 Million USD | -15.17% |
| 2019 FY | - USD | 115.4% |
| 2019 Q3 | 1.24 Million USD | -14.72% |
| 2019 Q1 | 2.05 Million USD | 34.42% |
| 2019 Q4 | 1.61 Million USD | 28.99% |
| 2019 Q2 | 1.46 Million USD | -28.71% |
| 2018 Q3 | 858.64 Thousand USD | -13.33% |
| 2018 Q1 | 1.07 Million USD | -34.13% |
| 2018 FY | - USD | -26.48% |
| 2018 Q4 | 1.52 Million USD | 78.11% |
| 2018 Q2 | 990.7 Thousand USD | -8.06% |
| 2017 Q3 | 1.37 Million USD | -5.06% |
| 2017 FY | - USD | -15.55% |
| 2017 Q1 | 1.6 Million USD | -8.19% |
| 2017 Q2 | 1.45 Million USD | -9.67% |
| 2017 Q4 | 1.63 Million USD | 18.65% |
| 2016 Q1 | 1.9 Million USD | -15.29% |
| 2016 FY | - USD | 32.58% |
| 2016 Q3 | 1.63 Million USD | -14.91% |
| 2016 Q4 | 1.75 Million USD | 7.26% |
| 2016 Q2 | 1.91 Million USD | 0.64% |
| 2015 FY | - USD | 32.19% |
| 2015 Q4 | 2.25 Million USD | 81.51% |
| 2015 Q3 | 1.23 Million USD | -11.49% |
| 2015 Q2 | 1.4 Million USD | 125.36% |
| 2015 Q1 | 621.66 Thousand USD | -40.1% |
| 2014 Q4 | 1.03 Million USD | 25.59% |
| 2014 FY | - USD | 61.86% |
| 2014 Q1 | 1 Million USD | 22.01% |
| 2014 Q2 | 1.22 Million USD | 21.96% |
| 2014 Q3 | 826.39 Thousand USD | -32.59% |
| 2013 FY | - USD | 372.42% |
| 2013 Q4 | 823.86 Thousand USD | 23.82% |
| 2013 Q2 | 489.07 Thousand USD | 11.94% |
| 2013 Q3 | 665.39 Thousand USD | 36.05% |
| 2013 Q1 | 436.89 Thousand USD | 74.74% |
| 2012 Q3 | -311.63 Thousand USD | -212.99% |
| 2012 Q4 | 250.02 Thousand USD | 180.23% |
| 2012 Q2 | 275.8 Thousand USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2011 Q1 | 668.74 Thousand USD | 18.94% |
| 2010 FY | - USD | 0.24% |
| 2010 Q4 | 562.26 Thousand USD | 59.43% |
| 2010 Q3 | 352.67 Thousand USD | -7.22% |
| 2010 Q1 | 192.84 Thousand USD | -42.98% |
| 2010 Q2 | 380.09 Thousand USD | 97.1% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | 338.19 Thousand USD | -19.35% |
| 2009 Q3 | 419.32 Thousand USD | 496.56% |
| 2009 Q2 | 70.29 Thousand USD | 0.0% |
| 2006 Q3 | 744.33 Thousand USD | 119.6% |
| 2006 Q4 | 382.47 Thousand USD | -48.62% |
| 2006 Q2 | 338.94 Thousand USD | -56.65% |
| 2006 Q1 | 781.82 Thousand USD | 173.7% |
| 2006 FY | - USD | 26.85% |
| 2005 Q3 | 427.25 Thousand USD | 31.28% |
| 2005 Q2 | 325.45 Thousand USD | -55.62% |
| 2005 FY | - USD | -11.81% |
| 2005 Q1 | 733.42 Thousand USD | 0.0% |
| 2005 Q4 | 285.65 Thousand USD | -33.14% |
| 2004 FY | - USD | 15.04% |
| 2003 FY | - USD | 34.2% |
| 2002 FY | - USD | 0.0% |
| 2001 Q1 | 251.49 Thousand USD | -27.81% |
| 2001 Q2 | 219.4 Thousand USD | -12.76% |
| 2001 Q3 | 211.62 Thousand USD | -3.54% |
| 2000 Q4 | 348.37 Thousand USD | 82.1% |
| 2000 FY | - USD | 65.19% |
| 2000 Q3 | 191.3 Thousand USD | -23.73% |
| 2000 Q2 | 250.82 Thousand USD | 41.19% |
| 2000 Q1 | 177.64 Thousand USD | -28.16% |
| 1999 FY | - USD | -31.07% |
| 1999 Q4 | 247.26 Thousand USD | 107.36% |
| 1999 Q2 | 48.28 Thousand USD | 0.0% |
| 1999 Q3 | 119.24 Thousand USD | 146.98% |
| 1998 FY | - USD | 130.24% |
| 1997 FY | - USD | 9.96% |
| 1996 FY | - USD | -21.74% |
| 1995 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | 360.726% |
| Arrayit Corporation | -3.07 Million USD | 198.529% |
| Atlantic International Corp. | -5.38 Million USD | 156.261% |
| Biocept, Inc. | -30.24 Million USD | 110.027% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | 500.362% |
| DermTech, Inc. | -97.89 Million USD | 103.098% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 99.896% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 114.98% |
| iMD Companies, Inc. | -154.65 Thousand USD | 2060.597% |
| IDenta Corp. | 71.58 Thousand USD | -4135.741% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 20.974% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | -7737.271% |
| InVitro International | 6680.00 USD | -45292.814% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | 155.781% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | 25089.616% |
| Medical Imaging Corp. | -896.74 Thousand USD | 438.14% |
| NovelStem International Corp. | -3.78 Million USD | 180.095% |
| Optigenex Inc. | -1.18 Million USD | 355.513% |
| PharmChem, Inc. | 1.05 Million USD | -187.741% |
| Proteome Sciences plc | -1.13 Million USD | 366.688% |
| Response Genetics, Inc | -19.66 Million USD | 115.419% |
| Rennova Health, Inc. | -234.81 Thousand USD | 1391.331% |
| RushNet, Inc. | -614.85 Thousand USD | 593.166% |
| ScreenPro Security Inc. | -3.43 Million USD | 188.278% |
| Stella Diagnostics Inc. | -5.7 Million USD | 153.128% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 129.525% |
| Todos Medical Ltd. | -9.39 Million USD | 132.278% |